GlassScriptPhysician profile
Yongqing Feng
NPI 1497806988
$1,189.70
in general payments reported to CMS, 2019-2025
14 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $150 · 2021: $87.91 · 2022: $303 · 2023: $248 · 2024: $174 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $712.59 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Merck Sharp & Dohme LLC | $86.19 | 2022-2023 | Verquvo |
| Glaxosmithkline, LLC. | $73.39 | 2022-2024 | Trelegy Ellipta, Arexvy |
| Dexcom, INC. | $59.69 | 2022 | |
| Janssen Pharmaceuticals, INC | $50.76 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.34 | 2022-2025 | Jardiance |
| Redhill Biopharma INC. | $37.63 | 2020-2023 | Talicia |
| Nestle Healthcare Nutrition INC. | $27.94 | 2023 | |
| Abbvie INC. | $20.84 | 2025 | |
| Scilex Pharmaceuticals INC. | $16.81 | 2019 | |
| Amgen INC. | $16.76 | 2023 | Prolia, Evenity |
| Amarin Pharma, INC. | $16.19 | 2021 | |
| Novo Nordisk INC | $12.69 | 2022 | |
| Novartis Pharmaceuticals Corporation | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yongqing Feng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.